Scientists investigate why some thyroid cancers resist radioactive iodine
NCT ID NCT07314255
First seen Jan 06, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This study examines why some papillary thyroid cancers respond well to radioactive iodine therapy while others do not. Researchers will compare tissue samples and PET-CT scans from 60 patients who have already had treatment. The goal is to understand how a protein called Trop2 influences treatment sensitivity and cancer progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TROP2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, 330000, China
Conditions
Explore the condition pages connected to this study.